Mirum Pharmaceuticals Enters into Definitive Agreement to Acquire Bluejay Therapeutics, Expanding Global Leadership in Rare Disease
8 December 2025
Download
SWIXX AND LUNDBECK PARTNERSHIP GOES LIVE
1 December 2025
Download
Valo Health Announces Collaboration with Merck KGaA, Darmstadt, Germany to Discover and Develop Novel Treatments for Parkinson’s Disease and Related Disorders
20 November 2025
Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S.
18 November 2025
Download
Numab Therapeutics and Kaken Pharmaceutical Announce Licensing and Co-development Agreement for Multispecific Antibody NM81 in Inflammatory Bowel Disease (IBD)
13 November 2025
Download
Fangzhou and Fosun Pharma Forge Strategic Alliance to Deliver AI-Powered Psoriasis Management
29 October 2025
Download
Biotech-Aktien: Aufwinde beflügeln auch Kurse von Schweizer Beteiligungsgesellschaften
27 October 2025
Download
Electra Therapeutics Announces $183 Million Series C Financing to Advance First-in-Class SIRP-Targeted Therapies for Immune Disorders and Cancer
22 October 2025
Download
Mit HBM auf den Biotech-Aufschwung setzen
22 October 2025
Download
Aculys Pharma Acquired by Viatris
16 October 2025
Download
Genmab to Acquire Merus Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
29 September 2025
Download
Numab Therapeutics Achieves Milestone in Collaboration with Boehringer Ingelheim
25 September 2025
Download
89bio, Inc. Announces Agreement to be Acquired by Roche
18 September 2025
Download
Monte Rosa Therapeutics Anounces Colaboration with Novartis for Degraders to Treat Imune-mediated Diseases Degraders to Treat Immune-mediated Diseases
15 September 2025
Download
Fangzhou and Innovent Biologics Form Strategic Alliance for AI-Powered Weight Management Solutions
10 September 2025
Download
LUNDBECK SELECTS SWIXX AS A KEY PARTNER IN A TRANSFORMATIVE MULTI-REGIONAL DEAL
10 September 2025
Download
Arrivent Presents the Final Analysis of Firmonertinib Monotherapy Data from Global Phase 1b Study in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2025 World Conference on Lung Cancer
9 September 2025
Download
Upstream Bio Reports Positive Top-Line Results from the Phase 2 VIBRANT Trial of Verekitug for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
2 September 2025
Download
IO Biotech Announces Clinical Improvement in Progression Free Survival Demonstrated in Pivotal Phase 3 Trial of Cylembio® plus KEYTRUDA® (Pembrolizumab) for the Treatment of First-line Advanced Melanoma, but Statistical Significance Narrowly Missed
11 August 2025
Download
Freenome Announces Exclusive License Agreement with Exact Sciences to Commercialize Freenome’s Blood-Based Screening Test for Colorectal Cancer
6 August 2025
Download
SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics
5 August 2025
Download
Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
22 July 2025
Download
Fangzhou and Novo Nordisk Signed Collaboration Memorandum to Establish a New Ecosystem for Health Management
18 July 2025
Download
Neuron23 Announces $96.5 Million Series D Financing and First Patient Dosed in Global Phase 2 NEULARK Clinical Trial of NEU-411 for Early Parkinson’s Disease
25 June 2025
Download
Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC
22 May 2025
Download